GlassScriptPhysician profile
Anthony Keith Martin
NPI 1477570927
$1,017.98
in general payments reported to CMS, 2019-2025
28 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $112 · 2020: $144 · 2021: $232 · 2022: $117 · 2023: $73.15 · 2024: $179 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $412.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.21 | 2020 | |
| Ethicon US, LLC | $88.68 | 2025 | Harmonic, Megadyne |
| Myriad Genetic Laboratories, INC. | $85.20 | 2021-2022 | |
| Elucent Medical | $79.57 | 2021-2024 | |
| Stryker Corporation | $72.57 | 2024 | 1788 |
| Hologic INC | $56.23 | 2022 | |
| Cardinal Health 414 LLC | $43.49 | 2019 | |
| Merck Sharp & Dohme LLC | $43.06 | 2025 | Keytruda, Lynparza |
| Davol INC. | $39.16 | 2019 | |
| Edwards Lifesciences Corporation | $34.83 | 2024 | |
| Medtronic, INC. | $34.30 | 2021 | |
| Kerecis Limited | $31.47 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $29.99 | 2019-2021 | |
| Hologic Sales and Service, LLC | $26.53 | 2023 | Trident Specimen Radiography System, Localizer |
| Convatec INC. | $24.03 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $20.12 | 2020 | |
| Becton, Dickinson and Company | $19.72 | 2021 | |
| Kci USA, INC. | $19.16 | 2021 | |
| Abbvie INC. | $17.57 | 2023 | |
| Innocoll Pharmaceuticals Limited | $16.23 | 2022 | |
| Olympus America INC. | $15.93 | 2024 | 4k Cable 8.5m |
| Lemaitre Vascular, INC. | $15.65 | 2023 | Artegraft Vascular Graft |
| Boston Scientific Corporation | $15.16 | 2025 | Spyglass Discover |
| Teleflex LLC | $13.92 | 2025 | Deknatel |
| Heron Therapeutics, INC. | $13.40 | 2023 | Aponvie |
| Smith+Nephew, INC. | $13.19 | 2019 | |
| Allergan, INC. | $12.67 | 2021 | |
| Hollister Incorporated | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.